
This article explores the evolving landscape of primary aldosteronism, a prevalent but often under-diagnosed cause of hypertension. With outdated diagnostic tools and enhanced cardiovascular risk, the condition's significance is underscored. Molecular insights into aldosterone production and cell survival pave the way for novel therapeutic possibilities, potentially transforming patient outcomes.
Like
Save
Share